Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
Source: Fortune ·
A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.
From the source
Semaglutide—the diabetes and weight-loss drug known by brand names like Ozempic and Wegovy—is continuing to show its potential to treat a wide range of other conditions. While recent studies have revealed that these drugs may help stop opioid addiction, smoking, and even help people live longer, a new study published in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association now also links semaglutide to a decreased risk of Alzheimer’s disease. In the study, researchers at Case Western Reserve School of Medicine analyzed three years of electronic records of nearly one million Americans with type 2 diabetes. They compared patients using semaglutide programs—a glucagon-like peptide-1 (GLP-1) receptor agonist—to those prescribed one of seven other anti-diabetic drugs, including metformin, dipeptidyl-peptidase-4 inhibitors (DPP-4i), and other GLP-1RAs (which mimic the effects of GLP-1s). Patients prescribed semaglutide had a 40% to 70% reduced risk of first-time…